Haoliang Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Haoliang Huang has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Fang Ren
Department of Gynecologic Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
1 shared publication - Huirong Shi
Department of Obstetrics and Gynecology, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
1 shared publication - Qinghua Wu
Department of Obstetrics and Gynecology, First Affiliated Hospital, Zhengzhou University, NO.1 Jianshe Road, Zhengzhou, Henan, 450052, P.R. China
1 shared publication - Ruitao Zhang
Department of Gynecology, First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China
1 shared publication - Zhimin Chen
Department of Obstetrics and Gynecology, First Affiliated Hospital, Zhengzhou University, NO.1 Jianshe Road, Zhengzhou, Henan, 450052, P.R. China
1 shared publication
Latest Publications
- Open Access
- 16 September 2011
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 30 (1) , 83
Effects of metastasis-associated in colon cancer 1 inhibition by small hairpin RNA on ovarian carcinoma OVCAR-3 cells
Metastasis-associated in colon cancer 1 (MACC1) is demonstrated to be up-regulated in several types of cancer, and can serve as biomarker for cancer invasion and metastasis. To investigate the relations between MACC1 and biological processes of ovarian cancer, MACC1 specific small hairpin RNA (shRNA) expression plasmids were used to investigate the effects of MACC1 inhibition on ovarian carcinoma OVCAR-3 cells.
- 16 September 2011
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 30 (1) , 83
Open AccessEffects of metastasis-associated in colon cancer 1 inhibition by small hairpin RNA on ovarian carcinoma OVCAR-3 cells
Metastasis-associated in colon cancer 1 (MACC1) is demonstrated to be up-regulated in several types of cancer, and can serve as biomarker for cancer invasion and metastasis. To investigate the relations between MACC1 and biological processes of ovarian cancer, MACC1 specific small hairpin RNA (shRNA) expression plasmids were used to investigate the effects of MACC1 inhibition on ovarian carcinoma OVCAR-3 cells.